August 3, 2026 — Beeline Holdings (NASDAQ: BLNE) was featured in an article that discussed its recent acquisition of artificial intelligence company MagicBlocks, bringing in-house the technology that already powers key components of its mortgage platform. The move gives the digital platform greater control over AI development across mortgage origination, title services, home equity products and future digital real estate transactions.
August 3, 2026 — Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.
August 3, 2026 — Magnolia Oil & Gas (NYSE: MGY) priced its previously announced underwritten public offering of 46. 3 million shares of Class A common stock at $23.
August 3, 2026 — The Texas Stock Exchange (“TXSE”) officially launched trading Friday, becoming the first new major U. S.
August 3, 2026 — Safe Pro Group (NASDAQ: SPAI) secured a new U. S.
August 3, 2026 — MindWave Innovations (NYSE American: APUS), a wholly owned subsidiary of Apimeds Pharmaceuticals US Inc. (NYSE American: APUS), announced that its NILA token is now available to eligible U.
August 3, 2026 — Chinese battery maker Contemporary Amperex Technology Co. Limited (CATL) has strengthened its position as the world’s largest electric vehicle (EV) battery manufacturer.
August 3, 2026 — Thermal coal imports into Asia have surged for the third consecutive month, backed by summer demand from Japan, South Korea, and other major players. Despite the region’s notable commitment to renewables, Asia currently consumes nearly 90% of global seaborne thermal coal.
August 3, 2026 — Gold’s price peaked in January at $5,589 per ounce. Today, bullion is hovering around $4,073.
August 3, 2026 — Oncotelic Therapeutics (OTCQB: OTLC) announced that CEO and Chairman Dr. Vuong Trieu will present at the OTCQB Virtual Investor Conference on Aug.
August 3, 2026 — Solowin Holdings (NASDAQ: AXG), through its regulated stablecoin issuer AX Coin Bahrain B. S.
August 3, 2026 — Tonix Pharmaceuticals (NASDAQ: TNXP) announced it received official minutes from a Type C meeting with the U. S.
August 3, 2026 — NextPlat (NASDAQ: NXPL, NXPLW) announced it will release financial results for the second quarter ended June 30, 2026, on Aug. 13, 2026, and host a conference call that morning at 8:30 a.
August 3, 2026 — American Fusion (OTC: AMFN) completed the initial phase of its Texatron(TM) Fusion Engine(TM) engineering and testing program at Texas Tech University, achieving key engineering milestones including successful operation of remote ignition and control systems, plasma switching, high-voltage testing in a controlled vacuum environment and validation of radiation monitoring systems using non-radioactive fusion fuel. The company reported no measurable radiation during the initial testing phase and said the engineering and diagnostic data collected will guide future development as it advances the Texatron platform through multiple phases of laboratory evaluation.
August 3, 2026 — American Fusion (OTC: AMFN) appointed Dr. Noah D’Amico as a strategic advisor, adding expertise in nuclear diagnostics, radiation measurements, vacuum systems and AI-assisted particle-track analysis as the company advances the next phase of its Texatron(TM) Fusion Engine(TM) testing program at Texas Tech University.
August 3, 2026 — Gaxos. ai (NASDAQ: GXAI) announced that its board of directors has authorized a share repurchase program allowing the company to buy back up to $1 million of its common stock.
August 3, 2026 — This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) completed its previously announced strategic transaction with Homeland Critical Minerals Corp.
August 3, 2026 — This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) appointed Michael Halstead as chief executive officer, effective immediately, as the clinical-stage company advances HLP003 through Phase 3 development and prepares for potential commercialization.
July 31, 2026 — Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article that discussed its efforts to advance GelrinC, a potentially first-in-class, off-the-shelf cartilage regeneration platform, and the company’s broader mission to establish a new standard of care in cartilage repair. “Regentis is developing regenerative biomaterial technology as healthcare shifts toward therapies designed to restore damaged tissue rather than simply manage symptoms.
July 31, 2026 — Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.
